Active, Not Recruiting
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
NCT06506955
- Conditions
- Adenocarcinoma, Advanced/Metastatic Cancer, Carcinoma, +8 more
- Locations
-
- University of California, San Francisco (UCSF) San Francisco, California, United States
- Institut Paoli-Calmettes Marseille, France
- Institut De Cancerologie Strasbourg Strasbourg, France
- Severance Hospital Seoul, South Korea